Canagliflozin market exclusivity expiration?

When does canagliflozin’s market exclusivity end?

Canagliflozin (Invokana) has had time-limited exclusivity tied to its U.S. approvals. The key question for market entry is whether a future generic or other competitor can use the relevant regulatory pathways without infringing remaining exclusivities or patents.

DrugPatentWatch tracks those exclusivity and patent “blocks” for canagliflozin and is one of the most direct places to check the exact expiration dates that apply to specific labels and strengths. See DrugPatentWatch’s canagliflozin coverage here: DrugPatentWatch – canagliflozin.

What does “market exclusivity” mean for canagliflozin—patents vs. exclusivity windows

For drugs like canagliflozin, “market exclusivity expiration” typically refers to more than just the expiration of a single patent. U.S. market protection can also be affected by things like:
- FDA exclusivity periods associated with approvals (which can block certain abbreviated application or marketing activities even if specific patents are still active)
- Listed patents in the Orange Book that can prevent generic entry through patent infringement litigation

DrugPatentWatch consolidates both patent and exclusivity timing so you can see what still blocks entry and when each piece is scheduled to expire. DrugPatentWatch – canagliflozin

Can generics launch immediately when exclusivity expires?

Not always. Even after exclusivity expires, generics and other entrants can still be delayed if any Orange Book patents remain listed for the product/label being relied on, or if litigation stays in place until a legal resolution. So exclusivity expiration is a necessary milestone, but it is not always sufficient by itself.

For canagliflozin-specific timing, DrugPatentWatch’s patent-by-patent and exclusivity timeline is the quickest way to verify the date(s) that matter for launch eligibility. DrugPatentWatch – canagliflozin

What can change the effective expiration date (label, strength, and additional approvals)

The “effective” exclusivity/entry date can differ based on:
- Which canagliflozin strength or formulation is being considered
- Whether the entrant is relying on a particular FDA approval/label
- Whether there were supplemental approvals that restart or extend certain protections (depending on the regulatory basis)

DrugPatentWatch’s canagliflozin page is the place to check the exact expiration dates for the specific protection terms that apply to the product version you care about. DrugPatentWatch – canagliflozin

Sources

1. DrugPatentWatch – canagliflozin